DHR Danaher Corporation

Q2 2025 10-Q

Filed: Jul 22, 2025Period ending Jun 27, 2025

Health Care

Industrial Instruments For Measurement, Display, and ControlSEC EDGAR

Danaher Corporation (DHR) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 22, 2025 for the fiscal period ending Jun 27, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• Newly added risk: Ongoing U.S.-China tariffs as of July 21, 2025, increasing supply costs and disrupting supply chains
• Most materially updated risk: Tariff-related cost surcharges and price increases affecting product demand and competitive positioning

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$5.9B

▲ +3.4% YoY▲ +3.4% QoQ

Net Income

$555M

▼ -38.8% YoY▼ -41.8% QoQ

Gross Margin

59.3%

▼ -34bp YoY▼ -181bp QoQ

Operating Margin

12.8%

▼ -753bp YoY▼ -939bp QoQ

Net Margin

9.3%

▼ -644bp YoY▼ -727bp QoQ

EPS (Diluted)

$0.78

▼ -36.6% YoY▼ -40.9% QoQ

Operating Cash Flow

$1.3B

▼ -5.6% YoY▲ +3.0% QoQ

Source: XBRL data from Danaher Corporation Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Danaher Corporation Quarterly Reports

Q3 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Danaher Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.